|
|
Case Studies in Multiple Sclerosis and Aging
• Identify the clinical difference between age-related/neurodegenerative cognitive decline and MS-related cognitive impairment.
• Discuss the role of potential biomarkers in identifying coexisting neurodegenerative disorders.
• Explain why it is important for the care team to address comorbid vascular risk factors for cognitive decline, including lifestyle modification and healthy behaviors
https://academycme.org/pdfs/MSAging.pdf |
|
|
Cleveland Clinic 15th Annual Neurology Update
The Cleveland Clinic 15th Annual Neurology Update addresses the latest clinically focused trends and most pertinent topics in the specialty. A faculty of 17 acclaimed experts provide the newest information regarding the diagnosis, medication and therapy for a wide range of neurologic conditions. Worth 15.5 AMA PRA Category I Credits™, this wealth of information will widen healthcare practitioners’ neurologic knowledge base and enhance patient care.
Topics include: Dementia, headache, ... |
|
|
Maximizing Outcomes in Patients with Cognitive Impairments - Dr. Robert Winningham
Patients with cognitive impairment often have difficulty with functional activities as well as learning or relearning behaviors in the clinic. Many clients are functioning below their potential, because of fear or other psychological barriers. In addition, depressed, unmotivated, apathetic and/or anxious clients often do not benefit from treatment as much as others. As you know, these patients often pose difficult challenges for therapists. In this exciting and unique 2 day course, we will lea... |
|